| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 959 | 19.206 | 14.853 | 10.724 | 10.296 | 10.320 | 12.699 | 13.320 |
| Total Income - EUR | - | - | 959 | 19.236 | 15.148 | 10.725 | 10.296 | 10.323 | 12.699 | 13.320 |
| Total Expenses - EUR | - | - | 783 | 20.594 | 15.779 | 9.016 | 12.072 | 12.473 | 13.805 | 12.760 |
| Gross Profit/Loss - EUR | - | - | 176 | -1.358 | -630 | 1.709 | -1.776 | -2.150 | -1.106 | 561 |
| Net Profit/Loss - EUR | - | - | 147 | -1.550 | -978 | 1.504 | -1.903 | -2.459 | -1.106 | 336 |
| Employees | - | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bloodfixmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 25 | 0 | 5.771 | 3.963 | 2.214 | 555 | 0 | 0 |
| Current Assets | - | - | 1.121 | 7.516 | 9.829 | 12.886 | 11.875 | 11.910 | 13.212 | 14.297 |
| Inventories | - | - | 0 | 5.143 | 5.903 | 8.623 | 10.298 | 11.364 | 12.580 | 13.736 |
| Receivables | - | - | 111 | 0 | 0 | 3 | 20 | 10 | 81 | 8 |
| Cash | - | - | 1.010 | 2.374 | 3.926 | 4.261 | 1.557 | 536 | 551 | 553 |
| Shareholders Funds | - | - | 191 | -1.363 | -2.314 | -766 | -2.652 | -5.120 | -6.210 | -5.840 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 955 | 8.879 | 17.914 | 17.616 | 16.742 | 17.585 | 19.422 | 20.137 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Bloodfixmed S.r.l.